10 MODULE VI (Part 1,2,3) Minor Blood Group Systems
10 MODULE VI (Part 1,2,3) Minor Blood Group Systems
10 MODULE VI (Part 1,2,3) Minor Blood Group Systems
7/10/2020
Lewis Blood Group System
• In 1955, Sneath and Sneath3 observed that red cells lacking Lea and Leb will take up
these antigens from plasma containing them. Equally, red cells expressing either
Lea or Leb will give these up to plasma lacking them. In other words, the antigens
were found to be soluble.
• Between 1948 and 1951, Grubb4,5 and Brendemoen6 independently observed that
the saliva of Le(a+b-) individuals strongly inhibited anti-Lea, and that the saliva of
the majority of Le(a-b+) individuals also inhibited anti-Lea, but did so less strongly.
• In 1963, Mollison et al7 demonstrated that this phenomenon also occurred in vivo.
• From this it can be seen that:
• Lewis antigens are not intrinsic to red cells.
• They are located on type 1 glycosphingolipids that are adsorbed onto the red cells
from the plasma.
• Lewis, therefore, is not strictly speaking, a red cell blood group
7/10/2020
Lewis System
• Chromosome 19
• Formation depends on interaction between Lewis
(LeLe, Lele), Secretor (SeSe, Sese), and Hh genes in the
tissues to produce Lewis antigen in the secretions.
• Lewis antigens have similar structures to ABO antigens.
• 2 alleles – dominant – (LeLe, Lele) >>>Lea
• lele – recessive – Lewis negative
Lewis Blood Group
7/10/2020
Lewis Blood Group
7/10/2020
Non-Secretors
• Le(a+b-)
• Genes present
– Le gene only
– No Se gene (sese)
– May or not have the H gene
• All Le(a+b-) – non secretors of ABH substances
• Non-secretors – sese – 20%
Secretors
• Le(a-b+)
• Genes present
– Le gene
– Se gene
– H gene
– Secretors – SeSe, Sese – 80%
Formation of Lewis Antigen
7/10/2020
Lea
7/10/2020
Leb
7/10/2020
Lewis Antibodies
• Almost always produced by Lea-, Leb-
• Naturally occurring, IgM, non red cell stimulated
• Clinically insignificant
• Reacts at room temp
• Binds complement – in vitro hemolysis
• Enhanced by enzymes
• Le(a-b+) individuals do not make anti-Lea because
Lea antigen structure is contained within the Leb
antigen epitope.
• Anti-Lea - made by Le(a-b-) people.
• Neutralized by Lewis blood group substances
Lewis Blood Group
7/10/2020
Summary
• Agglutination Inhibition
• 1. patient’s saliva boiled and cleared
• 2. saliva mixed with anti-A, Anti-B, anti-H
• 3. If soluble A,B,H antigens present in saliva ----these
will react with antibodies in reagent -----will
neutralize it –no available antibodies to agglutinate
test cells.
• 4. If there are no soluble A,B,H antigens in saliva,
antibodies in the reagent will not be neutralized and
are free to react with test cells.
Agglutination Inhibition
• Interpretation
• Agglutination – negative test
• No agglutination – positive test
I/i Blood Group System
• I antigens:
• Located below the ABH antigens
• When ABH sugars are removed by some enzymes, I activity
increases.
• I antigens - branched Type 2 chains
• Bombay – greatest amount of I antigens
• i antigen – at birth and infancy
• i antigen - linear Type 2 chains
• 18 months of life – i antigen decreases I increases
• HEMPAS (hereditary erythroblastic multinuclearity with
positive acidified serum test) – associated with greater i
activity on red cells than cord cells.
I Antibodies
• Benign anti-I – weak naturally occurring IgM
• Auto agglutinin reactive only at 4C
• Clinically insignificant
• Binds complement
• Anti-I demonstrates stronger reaction with red cells
having greater amounts of H - O and A2 red cells
• Pathologic anti-I – potent cold agglutinin reacts at
wide thermal range (0- 30C)
• Auto anti-I – mycoplasma pneumoniae
• Anti-i – IgM reacts at 4C
• Anti-i – infectious mononucleosis
Introduction - Kell
• These erythrocyte antigens are the third most potent
immunogenic antigen after ABO and Rh system, and are
defined by an immune antibody, anti-K. It was first noticed in
the serum of Mrs. Kellacher. She reacted to the erythrocytes
of her newborn infant resulting in hemolytic reactions. Since
then 25 Kell antigens have been discovered. Anti-K antibody
causes severe hemolytic disease of the fetus and newborn
(HDFN) and hemolytic transfusion reactions (HTR)
7/10/2020
Kell Blood Group System
• K (K1) - 9% frequency
• k (K2) - Cellano- 99-8% frequency
• Kpa (K3) - Penney - 2% frequency
• Kpb (K4) - Rautenberg - 99.9% frequency
• Jsa (K6) - Sutter - 20% (blacks), 0.1% whites
• Jsb (K7) - Matthews - 99% frequency
• Strongly immunogenic, ranks 2nd to D antigen
7/10/2020
Kell Antigen Biochemistry
• IgG
• Clinically significant
• Reactive at AHG phase
• Cause HDFN and HTR
• Do not bind complement
• Shows no enhancement or depletion with
enzymes
• Common antibody – next to ABO and Rh
Ko or Kell Null Phenotype
7/10/2020
Kx Blood Group System
7/10/2020
Duffy Blood Group System
• Fy - located on chromosome 1
• Fy locus - synthenic with Rh locus
• Fya, Fyb >>>produce Fya and Fyb antigens
• Fyx -encodes weakened Fyb antigen
• Fy - encodes no identifiable Duffy antigen
7/10/2020
Duffy Antibodies
• Anti-Fya, anti-Fyb
• IgG
• React at AHG phase
• Clinically significant
• Implicated with HDFN and DHTR
• Non reactive with enzymes
• Express dosage effect
• Anti-Fya more common than Anti-Fyb
Introduction
7/10/2020
Duffy System and Malaria
7/10/2020
MNSs Antigens
• Found on chromosome #4
• Inherited as haplotype (M,N) & (S,s)
• Found on red cells, not in body fluids and secretions.
• MN – associated with glycophorin A
• Ss –associated with glycophorin B
• Well developed at birth
• Important markers in paternity testing
• MNSs antigens - genetic nature is caused by
• crossing over, gene recombination, substitution.
MNSs Antibodies
• Mostly IgG
• Reactive at 37 C and at the antiglobulin phase
• Bind complement
• Associated with HDFN and HTR
• S+, s+ have U antigen
• S-,s- are also U negative
Introduction - Kidd
7/10/2020
Kidd Blood Group System
• Kidd Antigens
• Well developed at birth
• Causes HDFN
• In-vitro hemolysis
• Enhanced by enzyme treatment
Kidd Antibodies
• Anti-Jka, anti-Jkb
• Show dosage
• Clinically significant
• IgG , reacts at AHG
• Binds complement
• Transient, causes delayed HTR
• Anti-Jk3- produced by Jka- Jkb- individuals.
• Jk(a-b-) null phenotype - Far East, Pacific Islanders
• Jk(a-b-) more resistant to lysis in the presence of 2M
urea than Jka+, or Jkb+ cells.
P Blood Group System
Phenotypes Detectable antigens Possible antibodies
P1 P, P1 -
P2 P Anti-P1
p - Anti-PP1Pk
• Anti-P1
• IgM found in the sera of P2 individuals
• Weak reactive at cold temp
• Neutralized with hydatid cyst fluid
– (P1 substance)
P Antibodies
• Anti-P, P1, Pk
– Igg and IgM
– Reacts at wide thermal range
– Binds complement
– Potent hemolysins
– Associated with spontaneous abortion
– In-vitro hemolysis
Introduction - Lutheran
7/10/2020
Lutheran Blood Group System
• Lutheran Antigens:
• Poorly developed at birth
• Show dosage effect
• Gene located on chromosome #19
• Closely linked with the secretor locus
• Resistant to enzymes (ficin, papain)
Lu(a-b-)
• Anti-Lub
• IgG immune antibodies
• React at AHG – 37C
• Bind complement
• Mixed field reactivity
• Associated with transfusion reactions.
• Mild cases of HDFN
Other Minor Blood Groups
• Anti-Ch
• Anti-Rg
• Anti-Kn
• Anti-McC
• Anti-Yka
• Anti-Csa
• Anti-JMH
References.
• Mourant AE. A ‘new’ human blood group antigen of frequent
occurrence. Nature 1946; 158: 237-238.
• Andresen PH. The blood group system L: a new blood group L2. A case of epistasy
within the blood groups. Acta Path Microbiol Scand 1948; 25: 728-731.
• Sneath JS, Sneath PHA. Transformation of the Lewis groups of human red
cells. Nature 1955; 176: 172.
• Grubb R. Correlation between Lewis blood groups and secretor status in man. Nature,
Lond 1948; 162: 933.
• Grubb R. Observations on the human blood group system Lewis. Acta Path Microbiol
Scand 1951; 28: 61-81.
• Brendemoen OJ. Studies of agglutination and inhibition in two Lewis antibodies. J Lab clin
Med 1949; 34: 538-542.
• Mollison PL, Polley MJ, Crome P. Temporary suppression of Lewis blood-group antibodies to
permit incompatible transfusion. Lancet 1963; 1: 909-912
7/10/2020